← 10x Genomics, Inc. TXG
Market Price
$56.08
Market Cap
$7.63B
P/E Ratio
N/A
Revenue (FY 2025)
↑5.2% YoY
$642.82M
3-Yr CAGR: 7.6%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↑2,371.2% YoY
$130.12M
FCF Yield: 1.71%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TXG)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $71.1M | — | $70.3M | — | — | — | — | $-10.7M | $-14.5M | — |
| FY 2018 | $146.3M | +105.8% | $143.9M | — | — | — | — | $-76.4M | $-82.7M | -472.1% |
| FY 2019 | $245.9M | +68.1% | $242.8M | — | — | — | — | $34.6M | $-8.1M | +90.2% |
| FY 2020 | $298.8M | +21.5% | $297.2M | — | — | — | — | $-217.9M | $-254.6M | -3,037.0% |
| FY 2021 | $490.5M | +64.1% | $489.6M | — | — | — | — | $-21.4M | $-122.7M | +51.8% |
| FY 2022 | $516.4M | +5.3% | $515.9M | — | — | — | — | $-33.6M | $-165.3M | -34.7% |
| FY 2023 | $618.7M | +19.8% | $618.7M | — | — | — | — | $-15.2M | $-63.8M | +61.4% |
| FY 2024 | $610.8M | -1.3% | $610.8M | — | — | — | — | $6.7M | $-5.7M | +91.0% |
| FY 2025 | $642.8M | +5.2% | $443.9M | — | — | — | — | $136.1M | $130.1M | +2,371.2% |
Valuation
Market Price
$56.08
Market Cap
$7.63B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
8.47
FCF Yield
1.71%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
69.05%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.62x
Revenue 3-Yr CAGR
7.57%
Financial Health & Liquidity
Current Ratio
0.56
Cash Ratio
11.86
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$473.97M
Total Debt
N/A
Book Value / Share
$6.62
Cash Flow Efficiency
Operating Cash Flow
$136.05M
Capital Expenditures (CapEx)
$5.93M
Free Cash Flow
$130.12M
OCF / Revenue
21.16%
FCF / Revenue
20.24%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$6.62
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$1.04B
Total Liabilities
$1.04B
Stockholders' Equity
$796.33M
Current Assets
$22.21M
Current Liabilities
$39.97M